These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 36133926)

  • 1. Predicting the Progression of Very Early Systemic Sclerosis: Current Insights.
    Bellocchi C; Chung A; Volkmann ER
    Open Access Rheumatol; 2022; 14():171-186. PubMed ID: 36133926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc.
    Bellocchi C; Assassi S; Lyons M; Marchini M; Mohan C; Santaniello A; Beretta L
    Arthritis Res Ther; 2023 Jan; 25(1):15. PubMed ID: 36707842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic sclerosis in adults. Part I: Clinical features and pathogenesis.
    Jerjen R; Nikpour M; Krieg T; Denton CP; Saracino AM
    J Am Acad Dermatol; 2022 Nov; 87(5):937-954. PubMed ID: 35131402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis.
    Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S
    Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.
    Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y;
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):68-75. PubMed ID: 30277860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum.
    Ferri C; Giuggioli D; Guiducci S; Lumetti F; Bajocchi G; Magnani L; Codullo V; Ariani A; Girelli F; Riccieri V; Pellegrino G; Bosello S; Foti R; Visalli E; Amato G; Benenati A; Cuomo G; Iannone F; Cacciapaglia F; De Angelis R; Ingegnoli F; Talotta R; Campochiaro C; Dagna L; De Luca G; Bellando-Randone S; Spinella A; Murdaca G; Romeo N; De Santis M; Generali E; Barsotti S; Della Rossa A; Cavazzana I; Dall'Ara F; Lazzaroni MG; Cozzi F; Doria A; Pigatto E; Zanatta E; Ciano G; Beretta L; Abignano G; D'Angelo S; Mennillo G; Bagnato G; Calabrese F; Caminiti M; Pagano Mariano G; Battaglia E; Lubrano E; Zanframundo G; Iuliano A; Furini F; Zanetti A; Carrara G; Rumi F; Scirè CA; Matucci-Cerinic M;
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):40-47. PubMed ID: 32301427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.
    Vettori S; Cuomo G; Iudici M; D'Abrosca V; Giacco V; Barra G; De Palma R; Valentini G
    J Clin Immunol; 2014 Aug; 34(6):663-8. PubMed ID: 24760110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial.
    van den Hombergh WMT; Kersten BE; Knaapen-Hans HKA; Thurlings RM; van der Kraan PM; van den Hoogen FHJ; Fransen J; Vonk MC
    Trials; 2018 Aug; 19(1):449. PubMed ID: 30134971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets.
    Nevskaya T; Pope JE; Turk MA; Shu J; Marquardt A; van den Hoogen F; Khanna D; Fransen J; Matucci-Cerinic M; Baron M; Denton CP; Johnson SR
    J Rheumatol; 2021 Nov; 48(11):1698-1717. PubMed ID: 33993109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing microvascular changes in systemic sclerosis diagnosis and management.
    Cutolo M; Sulli A; Smith V
    Nat Rev Rheumatol; 2010 Oct; 6(10):578-87. PubMed ID: 20703220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nailfold videocapillaroscopy in patients with systemic sclerosis.
    Kubo S; Smith V; Cutolo M; Tanaka Y
    Immunol Med; 2018 Sep; 41(3):113-119. PubMed ID: 30938276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.
    Moinzadeh P; Aberer E; Ahmadi-Simab K; Blank N; Distler JH; Fierlbeck G; Genth E; Guenther C; Hein R; Henes J; Herich L; Herrgott I; Koetter I; Kreuter A; Krieg T; Kuhr K; Lorenz HM; Meier F; Melchers I; Mensing H; Mueller-Ladner U; Pfeiffer C; Riemekasten G; Sárdy M; Schmalzing M; Sunderkoetter C; Susok L; Tarner IH; Vaith P; Worm M; Wozel G; Zeidler G; Hunzelmann N;
    Ann Rheum Dis; 2015 Apr; 74(4):730-7. PubMed ID: 24389298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undifferentiated connective tissue disease at risk for systemic sclerosis: Which patients might be labeled prescleroderma?
    Valentini G; Pope JE
    Autoimmun Rev; 2020 Nov; 19(11):102659. PubMed ID: 32942034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).
    Valentini G
    Autoimmun Rev; 2015 Mar; 14(3):210-3. PubMed ID: 25461837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
    van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
    Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study.
    D'Alto M; Riccardi A; Argiento P; Di Stefano I; Romeo E; Iacono AM; D'Andrea A; Fasano S; Sanduzzi A; Bocchino M; Docimo L; Tolone S; Russo MG; Valentini G
    Clin Exp Med; 2018 May; 18(2):237-243. PubMed ID: 28993902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.